Pandemic Did Not Slow Center of Breakthrough Medicines in King of Prussia’s Discovery Labs

By
Despite the pandemic, development of the Center for Breakthrough Medicines in King of Prussia’s Discovery Labs is on track to be done by the end of 2021. Image via Philadelphia Magazine.

Despite the pandemic, development of the Center for Breakthrough Medicines in King of Prussia’s Discovery Labs innovation hub is still on track to be finalized and occupied by the end of next year, writes Queen Muse for the Philadelphia Magazine.

Developer Brian O’Neill and biotech executive Audrey Greenberg have joined forces with health-care investment firm Deerfield Management from New York City to develop the 630,000-square-foot cell and gene therapy manufacturing facility.

The site broke ground in December 2019. When it is completed, the property will offer contract development and manufacturing organization space and research and development labs, as well as administrative offices and dining, daycare, and fitness amenities.

The development is one in a long line of projects that are part of the latest real estate boom in the Philadelphia area that is being driven by the bioscience sector. There is currently more than a million square feet of lab space under construction in the region being developed to house the area’s leading life sciences companies and biotech entrepreneurs.

Read more about the real estate boom at the Philadelphia Magazine by clicking here.

Advertisement